Statistics for Replimune Group (id:7803 REPL)
Valuation metrics
Market cap
1.02B
Enterprise value
400.08M
Trailing P/E (ttm)
-4.61
Forward P/E
-5.55
PEG ratio
-5.55
Price/Sales (ttm)
Price/Book (mrq)
2.68
Enterprise Value/Revenue
Enterprise Value/EBITDA
-1.76
Overview
Shares outstanding
68.42M
Float
43.83M
Shares short
7.05M
% Held by insiders
0.05%
% Held by institutions
1.04%
Average volume (10 days)
1.20M
Average volume (90 days)
Price summary
52-Week low
4.92
52-Week high
17.00
52-Week change
28.80%
Beta
1.19
50-Day moving average
11.51
200-Day moving average
9.11
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
March 31th, 2024
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
0.00%
Operational effectiveness
Return on assets
-27.07%
Return on equity
-50.32%
Income statement
Revenue (ttm)
0.00
Revenue per share (ttm)
0.00
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-226,706,000.00
Net income to common (ttm)
-213,022,000.00
Diluted EPS (ttm)
-3.04
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
432.06M
Total cash per share (mrq)
6.32
Total debt (mrq)
76.12M
Total Debt/Equity (mrq)
19.96
Current ratio (mrq)
1.01K%
Book value per share (mrq)
5.58
Cash flow
Cash flow statement
-181,095,008.00
Levered free cash flow (LFCF)
-113,402,000.00